What is the purpose of double blinding in clinical trials?
Lack of ability of a patient to do normal function is called as?
Which of the following is true about secular trend?
Which of the following diseases is NOT under international surveillance?
Which of the following is NOT a criterion for a disease to be screened?
Secondary attack rate reflects the ------ of a disease?
A woman exposed to multiple sexual partners has a 5 times increased risk for Carcinoma Cervix. What is the attributable risk?
Which diseases are transmitted by the Culex mosquito?
What is defined as a 'case' in Tuberculosis?
The second attack rate is minimum in which of the following diseases?
Explanation: **Explanation** In clinical trials, **blinding** (or masking) is a fundamental epidemiological tool used to eliminate **bias**—the systematic error that can influence the results of a study. **Why Option D is Correct:** Double blinding is the gold standard in clinical trials where **neither the investigator (observer) nor the participant (subject)** knows which group (study or control) the subject has been assigned to. * **Avoiding Subject Bias:** If a patient knows they are receiving a new "miracle drug," they may report subjective improvement due to the placebo effect or psychological expectations. * **Avoiding Observer Bias:** If the researcher knows who is receiving the intervention, they may subconsciously measure outcomes more favorably or provide extra care to the study group, skewing the data. **Analysis of Incorrect Options:** * **Option A:** Comparability between groups is achieved through **Randomization**, not blinding. Randomization ensures that both known and unknown confounding factors are distributed equally. * **Option B & C:** These are components of double blinding, but individually they describe **Single Blinding** (where only the subject is unaware). Option D is the most comprehensive answer for "double" blinding. **High-Yield Clinical Pearls for NEET-PG:** * **Single Blind:** Only the subject is unaware. * **Double Blind:** Subject and Investigator are unaware. (Most common in RCTs). * **Triple Blind:** Subject, Investigator, and the **Data Analyst** (Statistician) are unaware. This is the most secure method to prevent bias. * **The "Placebo"** is the tool used to maintain blinding. * **Randomization** is the "Heart of a Control Trial"; it eliminates **Selection Bias**.
Explanation: This question tests the understanding of the **WHO International Classification of Impairments, Disabilities, and Handicaps (ICIDH)**, which describes the sequence of events following a disease. ### **Explanation of the Correct Answer** **Disability** is defined as any restriction or lack of ability (resulting from an impairment) to perform an activity in the manner or within the range considered normal for a human being. While impairment is at the organ level, **disability is at the personal level**, focusing on the functional performance of the individual. ### **Analysis of Incorrect Options** * **A. Impairment:** This refers to any loss or abnormality of psychological, physiological, or anatomical structure or function (e.g., loss of a limb or a damaged optic nerve). It occurs at the **organ level**. * **B. Disease:** This is the underlying pathological process or a harmful deviation from the normal structural or functional state of an organism. * **D. Handicap:** This is a disadvantage for a given individual, resulting from an impairment or a disability, that limits or prevents the fulfillment of a role that is normal for that individual. It occurs at the **social level** (e.g., inability to hold a job due to the disability). ### **High-Yield Clinical Pearls for NEET-PG** To differentiate these easily, remember the **WHO Sequence of Events**: **Disease → Impairment → Disability → Handicap** * **Example (Road Traffic Accident):** 1. **Disease:** Fracture of the femur. 2. **Impairment:** Loss of movement in the leg (Anatomical/Functional loss). 3. **Disability:** Inability to walk (Functional limitation). 4. **Handicap:** Unemployment (Social disadvantage). * **Key Distinction:** Impairment = Organ level; Disability = Personal level; Handicap = Social level. * **Rehabilitation** aims to reduce the impact of disability and handicap, even if the impairment cannot be fully reversed.
Explanation: **Explanation:** The term **Secular Trend** refers to the long-term changes in the occurrence of a disease over a prolonged period (usually decades). These changes are characterized by a **consistent increase or decrease** in the frequency of a disease in a particular direction. **Why the correct answer is right:** Option D is correct because secular trends reflect the progressive movement of a disease over time. For example, the global decrease in Polio or the steady increase in Non-Communicable Diseases (NCDs) like Diabetes and Coronary Heart Disease in India over the last 30 years are classic secular trends. **Analysis of incorrect options:** * **Option A:** Roadside accidents are examples of **Sporadic** or **Cyclical** occurrences, but they do not follow a long-term secular pattern unless analyzed over decades to show a steady rise/fall. * **Option B:** While environmental factors can influence disease, secular trends are often driven by complex interactions of socioeconomic changes, lifestyle shifts, and improvements in medical technology. * **Option C:** Variation in herd immunity typically leads to **Cyclical or Periodic trends** (e.g., Measles outbreaks every 2-3 years in unvaccinated populations), not long-term secular trends. **High-Yield Pearls for NEET-PG:** * **Secular Trend:** Long-term (decades). Example: Rise in Lung Cancer, decline in Rheumatic Heart Disease. * **Periodic/Cyclical Trend:** Short-term fluctuations (years). Example: Measles, Influenza. * **Seasonal Trend:** Within a year. Example: Diarrhea in summers, Upper Respiratory Infections in winters. * **Point Source Epidemic:** All cases occur within one incubation period (e.g., Food poisoning).
Explanation: To understand this question, it is essential to distinguish between the **International Health Regulations (IHR)** and the list of diseases under **International Surveillance**. ### **Why Yellow Fever is the Correct Answer** Yellow fever is categorized as a **Quarantinable Disease** (along with Plague and Cholera) under the International Health Regulations. These diseases require immediate notification to the WHO because they have the potential for rapid international spread. While they are monitored globally, they are technically classified under "International Health Regulations" rather than the specific list of "Diseases under International Surveillance." ### **Analysis of Incorrect Options** The WHO established a specific list of diseases under international surveillance to monitor their global trends, even if they don't always require immediate quarantine measures. * **A. Paralytic Polio:** Included in the surveillance list to monitor the progress of the Global Polio Eradication Initiative. * **C. Louse-borne Typhus Fever:** Included due to its potential for outbreaks in crowded, unsanitary conditions (e.g., refugee camps). * **D. Relapsing Fever:** Specifically the louse-borne variety, it is monitored internationally to prevent cross-border transmission. ### **High-Yield Clinical Pearls for NEET-PG** * **Diseases under International Surveillance (WHO):** Louse-borne typhus, Relapsing fever, Paralytic polio, Malaria, Viral influenza, and SARS. * **Quarantinable Diseases (IHR 1969):** Cholera, Plague, and Yellow Fever. * **IHR 2005 Update:** The focus shifted from specific diseases to "Public Health Emergencies of International Concern" (PHEIC). Under IHR 2005, any unusual or unexpected health event (including new strains of Flu or Ebola) must be reported. * **Yellow Fever Vaccination:** The certificate becomes valid **10 days** after vaccination and lasts for **life** (as per 2016 amendments).
Explanation: ### Explanation The core objective of **screening** is the presumptive identification of unrecognized disease in an **apparently healthy (asymptomatic)** population. **Why Option D is the Correct Answer (The "NOT" Criterion):** Screening is designed to detect disease during the **pre-symptomatic phase** (the period between biological onset and the appearance of symptoms). If a test only detects a disease *after* the onset of signs and symptoms, it is considered a **diagnostic test**, not a screening test. Therefore, Option D contradicts the fundamental definition of screening. **Analysis of Incorrect Options (Criteria for Screening):** * **Option A:** For screening to be ethical and useful, an **effective treatment** must be available. It is considered unethical to screen for a condition if no intervention can alter the outcome. * **Option B:** The **prevalence** must be high enough to justify the resources spent. Screening for extremely rare diseases results in a low Positive Predictive Value (PPV) and high costs per case detected. * **Option C:** This refers to the **cost-benefit ratio**. The benefits (reduced morbidity/mortality) must outweigh the physical risks (side effects of the test) and financial costs of the program. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson and Jungner Criteria:** These are the gold standard criteria for screening (1968). * **Iceberg Phenomenon:** Screening is primarily aimed at the "submerged portion" of the iceberg (latent, undiagnosed, or asymptomatic cases). * **Lead Time:** The period between early detection by screening and the time when the disease would have been diagnosed naturally due to symptoms. * **Ideal Screening Test:** Should be simple, safe, inexpensive, reliable (consistent), and valid (high sensitivity and specificity).
Explanation: **Explanation:** **Secondary Attack Rate (SAR)** is defined as the number of exposed persons developing the disease within the range of the incubation period following exposure to a primary case. It is expressed as a percentage. 1. **Why Communicability is Correct:** SAR is the most sensitive indicator of **communicability** (infectiousness). It measures the spread of a disease from an infected person to susceptible contacts in a closed environment (like a household or dormitory). A high SAR indicates that the pathogen is highly contagious and spreads easily among contacts. 2. **Why Other Options are Incorrect:** * **Severity:** Refers to the degree of illness caused. It is often measured by the proportion of cases requiring hospitalization or resulting in disability. * **Fatality:** Measured by the **Case Fatality Rate (CFR)**, which represents the killing power of a disease (number of deaths among diagnosed cases). * **Virulence:** This is the ability of an infectious agent to cause severe disease or death. While related to severity, it is a property of the pathogen, whereas SAR is a measure of transmission dynamics. **High-Yield NEET-PG Pearls:** * **Formula:** $\text{SAR} = \frac{\text{Number of exposed persons developing disease within one incubation period}}{\text{Total number of susceptible contacts}} \times 100$. * **Denominator Rule:** In the denominator, "Total number of susceptible contacts" **excludes** the primary case and those already immune (e.g., through prior infection or vaccination). * **Application:** SAR is used to evaluate the effectiveness of control measures (like isolation or prophylactic antibiotics) and to identify the "hidden" spread of infection.
Explanation: ### Explanation **1. Understanding the Correct Answer (C: 80%)** The question provides the **Relative Risk (RR)**, which is 5. The **Attributable Risk (AR)**, also known as the Etiologic Fraction among the exposed, measures the proportion of the disease in the exposed group that can be specifically attributed to the risk factor. The formula for Attributable Risk (Percent) is: $$\text{AR\%} = \frac{RR - 1}{RR} \times 100$$ Plugging in the values: $$\text{AR\%} = \frac{5 - 1}{5} \times 100 = \frac{4}{5} \times 100 = 80\%$$ This means that 80% of cervical cancer cases among women with multiple sexual partners can be attributed to that specific behavior, and these cases could potentially be prevented if the risk factor were eliminated. **2. Why Other Options are Incorrect** * **A (20%):** This represents $1/RR$. It does not correspond to the attributable risk formula. * **B (50%):** This would be the result if the RR was 2. * **D (100%):** This would only occur if the risk factor was the *sole* cause of the disease (RR = infinity), which is rarely the case in multifactorial diseases. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Relative Risk (RR):** Measures the *strength* of association. It is best for identifying the etiology of a disease. * **Attributable Risk (AR):** Measures the *impact* of a risk factor. It indicates how much of the disease can be prevented by removing the exposure (Clinical/Public Health importance). * **Population Attributable Risk (PAR):** Estimates the benefit to the *entire population* (both exposed and non-exposed) if the risk factor is removed. * **Cervical Cancer:** The primary etiological agent is Human Papillomavirus (HPV) types 16 and 18. Multiple sexual partners increase the risk of HPV transmission.
Explanation: ### Explanation The question asks for diseases transmitted by the **Culex** mosquito. However, based on the provided key, there is a discrepancy: **Dengue** is primarily transmitted by *Aedes aegypti*, while **Culex** is the primary vector for **Filariasis** and **Japanese Encephalitis (JE)**. In standard NEET-PG patterns, if this were a "Multiple Select" or "All except" question, the distinction is vital. #### 1. Why the Correct Answer (as per provided key) is Dengue: While *Aedes* is the classic vector for Dengue, certain studies and niche epidemiological contexts occasionally discuss other vectors, but in a standard examination, **Dengue is the wrong association for Culex.** If the key identifies Dengue as the "correct" choice in a "Which of the following is NOT" context, it would make sense. However, strictly speaking, **Filariasis (B)** and **Japanese Encephalitis (D)** are the hallmark diseases transmitted by Culex. #### 2. Analysis of Options: * **Malaria (A):** Transmitted by the female **Anopheles** mosquito. They typically bite at night and breed in clean, stagnant water. * **Filariasis (B):** Transmitted by **Culex quinquefasciatus** (the "nuisance mosquito"). It breeds in dirty, polluted water (sewage/sullage). * **Dengue (C):** Transmitted by **Aedes aegypti** (the "tiger mosquito"). Characterized by daytime biting and breeding in artificial containers of clean water. * **Japanese Encephalitis (D):** Transmitted by **Culex tritaeniorhynchus**. It breeds in irrigated rice fields and uses pigs/herons as reservoir hosts. #### 3. NEET-PG High-Yield Pearls: * **Culex Breeding:** Prefers dirty water (Filariasis) or rice fields (JE). * **Aedes Breeding:** Prefers "man-made" containers (flower pots, discarded tires). * **Vector for Zika/Chikungunya:** Also *Aedes aegypti*. * **West Nile Virus:** Another important disease transmitted by *Culex*. * **Flight Range:** *Culex* can fly long distances (up to 11 km), whereas *Aedes* has a very short flight range (<100 meters).
Explanation: ### Explanation In the context of public health and epidemiology, particularly under the National Tuberculosis Elimination Programme (NTEP) guidelines, a **'case'** of tuberculosis is traditionally defined by the microbiological demonstration of *Mycobacterium tuberculosis*. **1. Why Sputum AFB positive is the correct answer:** For epidemiological surveillance and initiation of standard treatment protocols, a **Sputum AFB (Acid-Fast Bacilli) positive** result is the gold standard for defining a "smear-positive case." It indicates that the individual is infectious and capable of transmitting the bacilli to others. In community medicine, identifying these cases is the priority for breaking the chain of transmission. **2. Why the other options are incorrect:** * **A. X-ray positive:** Chest X-rays are highly sensitive but lack specificity. Radiological shadows can be due to old healed TB, pneumonia, or fungal infections; therefore, an X-ray alone does not confirm an "active case" without clinical or microbiological correlation. * **B. Culture positive:** While culture is the "absolute gold standard" for diagnosis, it takes 2–8 weeks to yield results. For rapid epidemiological notification and starting treatment, sputum microscopy remains the primary diagnostic tool for defining a case. * **D. Tuberculosis positive:** This is a vague clinical term and not a standardized epidemiological definition. **3. High-Yield Clinical Pearls for NEET-PG:** * **Definitive Case:** Now defined as a patient with a positive culture, molecular test (CBNAAT/Truenat), or smear microscopy. * **Microbiologically Confirmed TB:** A patient with a positive biological specimen (Smear, Culture, or WRD like CBNAAT). * **Clinically Diagnosed TB:** A patient who does not meet microbiological criteria but is diagnosed based on X-ray, histology, or clinical signs and started on a full course of anti-TB treatment. * **Infectivity:** One smear-positive case, if left untreated, can infect **10 to 15** people in a year.
Explanation: **Explanation:** The **Secondary Attack Rate (SAR)** is a measure of the communicability of an infectious disease within a closed group (like a household). It represents the number of exposed individuals who develop the disease within the incubation period following exposure to a primary case. **Why Tuberculosis is the correct answer:** Tuberculosis (TB) has a very low SAR compared to typical childhood exanthematous diseases. This is because TB is a chronic infection with a long and variable incubation period. Transmission depends on several factors: the infectivity of the source (sputum positivity), the duration of exposure, and the host's immune status. Unlike highly contagious viral infections, only about 5–10% of people infected with *M. tuberculosis* will ever develop active disease in their lifetime. **Analysis of Incorrect Options:** * **Measles:** Has one of the highest SARs (approx. **80%**). It is highly contagious via respiratory droplets, and almost all susceptible contacts develop the disease. * **Whooping Cough (Pertussis):** Also has a very high SAR (approx. **60–80%**) among non-immune household contacts. * **Diphtheria:** While contagious, its SAR is lower than measles (approx. **20%**) but still significantly higher than the clinical attack rate of Tuberculosis. **High-Yield Clinical Pearls for NEET-PG:** * **SAR Formula:** (Number of exposed persons developing the disease within incubation period / Total number of exposed susceptible contacts) × 100. * **Denominator Rule:** The "Primary Case" is always excluded from both the numerator and the denominator. * **Highest SAR:** Measles and Pertussis. * **Lowest SAR:** Tuberculosis (among the given options). * **Utility of SAR:** It is used to determine the effectiveness of prophylactic measures (like vaccines) and to identify the "median" infectivity of a disease.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free